Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation. J Clin Oncol 2013 Jul 10;31(20):e351-2
Date
06/05/2013Pubmed ID
23733763DOI
10.1200/JCO.2012.45.7739Scopus ID
2-s2.0-84883875497 (requires institutional sign-in at Scopus site) 57 CitationsAuthor List
Munoz J, Schlette E, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, OralAdult
Antineoplastic Combined Chemotherapy Protocols
Biopsy, Needle
Blood Chemical Analysis
Dose-Response Relationship, Drug
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Indoles
Leukemia, Hairy Cell
Male
Mutation
Proto-Oncogene Proteins B-raf
Severity of Illness Index
Sulfonamides
Treatment Outcome
